advertisement
Reply
 
Thread Tools Display Modes
Old 10-31-2017, 01:20 PM #1
NewsBot NewsBot is offline
News Gatherer
Community Support Team
 
Join Date: Dec 2007
Posts: 65,355
15 yr Member
NewsBot NewsBot is offline
News Gatherer
Community Support Team
 
Join Date: Dec 2007
Posts: 65,355
15 yr Member
Post Anavex 2-73 Therapy Candidate Seen to Restore Brain Cell Function in Mice with Parkin


Parkinson's News Today


Anavex 2-73 Therapy Candidate Seen to Restore Brain Cell Function in Mice with Parkinson's, Study Finds
Parkinson's News Today
Anavex 2-73, an investigational therapy being evaluated in clinical trials for Alzheimer's disease, was found to restore the function of damaged nerve cells in mouse models of Parkinson's disease. Based on the favorable safety profile seen in the ...
Anavex Life Sciences Announces Additional Data at The Michael J. Fox Foundation's Parkinson's Disease ...GlobeNewswire (press release)

all 9 news articles »


More...
NewsBot is offline   Reply With QuoteReply With Quote

advertisement
Reply

Tags
anavex, therapy, 2-73, disease, function

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On


Similar Threads
Thread Thread Starter Forum Replies Last Post
Brain-penetrating nanoparticles restore neuron function Tupelo3 Parkinson's Disease 0 05-25-2017 12:28 PM


All times are GMT -5. The time now is 08:21 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.